Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.
Joushomme A, Désilets A, Champagne W, Hassanzadeh M, Lemieux G, Gravel-Trudeau A, Lepage M, Lafrenière S, Froehlich U, List K, Boudreault PL, Leduc R.
Joushomme A, et al. Among authors: lemieux g.
bioRxiv [Preprint]. 2024 Aug 29:2024.08.28.609965. doi: 10.1101/2024.08.28.609965.
bioRxiv. 2024.
PMID: 39257753
Free PMC article.
Preprint.